Ligand Pharmaceuticals (LGND) Other Working Capital Changes (2010 - 2023)
Ligand Pharmaceuticals (LGND) posted Other Working Capital Changes of -$207000.0 for Q1 2026, down 104.64% sequentially from $4.5 million in Q4 2025, and down 122.62% YoY from $915000.0 in Q1 2025.
Ligand Pharmaceuticals (LGND) Other Working Capital Changes (2010 - 2023) Analysis & Trends
Ligand Pharmaceuticals has reported Other Working Capital Changes for 11 years, with the latest figure at -$207000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 122.62% year-over-year to -$207000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (down 55.24% YoY) and the FY2025 annual result came in at $3.9 million, down 17.7% from the prior year.
- Other Working Capital Changes fell to -$207000.0 in Q1 2026 per LGND's latest filing, from $4.5 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $5.1 million in Q2 2020 and troughed at -$8.9 million in Q2 2021.
- A 4-year average of -$1.5 million and a median of -$881500.0 in 2020 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 2839.04% in 2024, down 9297.26% in 2024.
- Over 5 years, Other Working Capital Changes stood at -$1.2 million in 2022, then jumped by 144.22% to $513000.0 in 2023, then surged by 796.69% to $4.6 million in 2024, then slipped by 2.93% to $4.5 million in 2025, then slumped by 104.64% to -$207000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$207000.0, $4.5 million, and -$2.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ligand Pharmaceuticals | 5.87 Bn | 4.51 Bn | 60.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -98,000.00 |
| Mar 31, 2023 | -98,000.00 |
| Mar 31, 2023 | -98,000.00 |
| Sep 30, 2022 | 2.27 Mn |
| Sep 30, 2022 | 2.27 Mn |
| Sep 30, 2022 | 2.27 Mn |
| Jun 30, 2022 | 199,000.00 |
| Jun 30, 2022 | 199,000.00 |
| Jun 30, 2022 | 199,000.00 |
| Mar 31, 2022 | -2.45 Mn |
| Mar 31, 2022 | -2.45 Mn |
| Mar 31, 2022 | -2.45 Mn |
| Sep 30, 2021 | -6.09 Mn |
| Sep 30, 2021 | -6.09 Mn |
| Sep 30, 2021 | -6.09 Mn |
| Jun 30, 2021 | -8.91 Mn |
| Jun 30, 2021 | -8.91 Mn |
| Jun 30, 2021 | -8.91 Mn |
| Mar 31, 2021 | -5.70 Mn |
| Mar 31, 2021 | -5.70 Mn |